Skip to content
Screener

Arcturus Therapeutics ARCT Q3 2025 earnings

Reported November 10, 2025 · After market close

Revenue$17.2MBeat by $1.1M
EPS-$0.49Beat by $0.31
Revenue estimate$16.0M
EPS estimate-$0.80

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$8.0M
EPS estimate-$0.67

FAQ

When did Arcturus Therapeutics report Q3 2025 earnings?
Arcturus Therapeutics (ARCT) reported Q3 2025 earnings on November 10, 2025 after market close.
What were Arcturus Therapeutics's Q3 2025 revenue and EPS?
Arcturus Therapeutics reported revenue of $17.2M and eps of $-0.49 for Q3 2025.
Did Arcturus Therapeutics beat estimates in Q3 2025?
Revenue beat the consensus estimate of $16.0M by $1.1M. EPS beat the consensus estimate of $-0.80 by $0.31.
How did Arcturus Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 55.8% from $38.8M a year earlier and eps declined 88.5% from $-0.26.
Where can I find Arcturus Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193805-25-001555) and the 10-Q periodic report (0001193125-25-275758) directly on SEC EDGAR. The filing index links above go to sec.gov.